campestanol has been researched along with dinoprostone in 1 studies
| Studies (campestanol) | Trials (campestanol) | Recent Studies (post-2010) (campestanol) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 43 | 11 | 9 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | campestanol (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TC; Chung, MC; Lee, SY; Liu, WH; Shi, LS | 1 |
1 other study(ies) available for campestanol and dinoprostone
| Article | Year |
|---|---|
Antcamphin M Inhibits TLR4-Mediated Inflammatory Responses by Upregulating the Nrf2/HO-1 Pathway and Suppressing the NLRP3 Inflammasome Pathway in Macrophages.
Topics: Animals; Anti-Inflammatory Agents; Antrodia; Chemokine CXCL1; Dinoprostone; Drugs, Chinese Herbal; Ergosterol; Heme Oxygenase-1; Inflammasomes; Macrophages; Mice; NF-E2-Related Factor 2; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2019 |